Conmed (CNMD) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161.00 |
| Dec 31, 2025 | 250.00 |
| Sep 30, 2025 | -603.00 |
| Jun 30, 2025 | 2,949.00 |
| Mar 31, 2025 | 76.00 |
| Dec 31, 2024 | 611.00 |
| Sep 30, 2024 | 1,378.00 |
| Jun 30, 2024 | 857.00 |
| Mar 31, 2024 | 904.00 |
| Dec 31, 2023 | 407.00 |
| Sep 30, 2023 | 354.00 |
| Jun 30, 2023 | 4.00 |
| Mar 31, 2023 | -534.00 |
| Dec 31, 2022 | -1,242.00 |
| Sep 30, 2022 | 115.00 |
| Jun 30, 2022 | -3,798.00 |
| Mar 31, 2022 | 1,074.00 |
| Dec 31, 2021 | 656.00 |
| Sep 30, 2021 | 160.00 |
| Jun 30, 2021 | 435.00 |
| Mar 31, 2021 | 597.00 |
| Dec 31, 2020 | -62.00 |
| Sep 30, 2020 | -59.00 |
| Jun 30, 2020 | -2,678.00 |
| Mar 31, 2020 | -370.00 |
| Dec 31, 2019 | -147.00 |
| Sep 30, 2019 | 352.00 |
| Jun 30, 2019 | -491.00 |
| Mar 31, 2019 | -961.00 |
| Dec 31, 2018 | 115.00 |
| Sep 30, 2018 | -102.00 |
| Jun 30, 2018 | -195.00 |
| Mar 31, 2018 | -145.00 |
| Dec 31, 2017 | 46.00 |
| Sep 30, 2017 | -246.00 |
| Jun 30, 2017 | -392.00 |
| Mar 31, 2017 | -1,157.00 |
| Dec 31, 2016 | 2,780.00 |
| Sep 30, 2016 | -220.00 |
| Jun 30, 2016 | -554.00 |
| Mar 31, 2016 | -961.00 |
| Dec 31, 2015 | 19.00 |
| Sep 30, 2015 | 68.00 |
| Jun 30, 2015 | -52.00 |